The present study investigated whether the selective nociceptin opioid peptide (NOP) receptor agonist, Ro64-6198, impairs acquisition of fear conditioning through glutamatergic mechanisms. Systemic administration of Ro64-6198 (0.3 and 1 mg/kg) or the non-competitive NMDA receptor antagonist, MK-801 (0.03 and 0.1 mg/kg) prior to conditioning severely impaired contextual but not cued fear learning in C57BL/6N mice. When administered together at sub-effective doses, Ro64-6198 (0.5 mg/kg) and MK-801 (0.05 mg/kg), synergistically impaired contextual fear learning, but left cued fear learning intact. We next used the immediate shock deficit paradigm (ISD) to examine the effects of Ro64-6198 and MK-801 on contextual memory formation in the absence of the foot-shock. As expected, naive mice that were shocked briefly after being placed in the training chamber displayed no contextual fear conditioning. This learning deficit was elevated by prior exposure of mice to the training context. Furthermore, administration of Ro64-6198 and MK-801, either separately at amnesic doses (1 mg/kg and 0.1 mg/kg, respectively) or concomitantly at sub-effective doses (0.5 mg/kg and 0.05 mg/kg, respectively) significantly reduced the facilitating effects of context preexposure. These findings demonstrate the existence of functional antagonism between NOP and NMDA receptors that predominantly contributes to modulation of conditioned fear learning which involves spatial-processing demands.
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Introduction
Nociceptin/orphanin FQ (N/OFQ) is a 17-amino acid neuropeptide identified as the endogenous agonist ligand of the nociceptin opioid peptide (NOP) receptor, previously referred to as opioidreceptor-like 1 (ORL1). Although N/OFQ peptide and its receptor show some structural homology with the opioid peptides and receptors, they constitute a novel neuromodulatory system that is pharmacologically distinct from the opioid family (Calo' et al., 2000; Meis, 2003) . There is growing evidence that N/OFQ-NOP system modulates learning and memory processes. N/OFQ and NOP receptors are highly expressed in cortical and limbic structures underlying learning and memory processes (septum, amygdaloid complex and the hippocampal formation) (Darland & Grandy, 1998; Neal et al., 1999a,b) . Furthermore, systemic administration of the synthetic NOP receptor agonist, Ro64-6198, or intracerebral infusions of N/OFQ peptide causes memory deficits in various cognitive tasks, including step-down passive avoidance, fear conditioning, object recognition and Morris water-maze procedures (Fornari, Soares, Ferreira, Moreira, & Oliveira, 2008; Goeldner et al., 2008; Higgins et al., 2002; Nabeshima, Noda, & Mamiya, 1999; Redrobe, Calo', Guerrini, Regoli, & Quirion, 2000; Sandin, Georgieva, Schott, Ogren, & Terenius, 1997) . Conversely, mice deficient in the N/OFQ precursor peptide or in the NOP receptor displayed improved learning abilities (Higgins et al., 2002; Mamiya et al., 2003; Manabe et al., 1998) . Similarly, pharmacological blockade of NOP receptors in the amygdala enhanced long-term consolidation of fear memory in rat (Roozendaal, Lengvilas, McGaugh, Civelli, & Reinscheid, 2007) . Together, these findings indicate that endogenous N/OFQ peptide negatively modulates learning and memory abilities.
Although N/OFQ-NOP-receptor system role in cognition is now well accepted, the precise mechanisms of action remain poorly understood. Previous electrophysiologic and neurochemical studies have demonstrated that N/OFQ peptide inhibits neurotransmitter release and synaptic plasticity in the hippocampus and amygdala (Bongsebandhu-phubhakdi & Manabe, 2007; Kawahara, Hesselink, van Scharrenburg, & Westerink, 2004; Manabe et al., 1998; Meis, 2003; Wei & Xie, 1999; Yu, Fein, Phan, Evans, & Xie, 
